baber/WOPTO huggingface dataset:
Patent PT-1961090-E (PT)
Title: Spark plug
Inventor: KUHNERT DIETER
IPC: H01T13/04
Filed: 2006-11-29
Abstract: A spark plug for igniting a combustible gas mixture in an internal combustion engine includes an ignition electrode with an electrical supply line is connected thereto. A pipe housing is provided for enclosing the electrical supply line and a venting channel is provided for discharging combustion gases from the pipe housing. The venting channel provides for discharging combustion gases infiltrating the spark plug as leakage gases run along the supply line.
Patent PT-1984591-E (PT)
Title: Pushbutton combination lock
Inventor: TALPE JOSEPH
IPC: E05B13/08
Filed: 2006-12-13
Abstract: The lock comprises a lock bolt, in particular a latch bolt (17), the actuating mechanism (22) of which can be locked by means of a locking mechanism which comprises preferably one series of pushbuttons on each side of the lock. The pushbuttons act on code and blocking tumbler members (33) so that when the correct number combination is put in, one of the two check slides is released. A selector (59) couples the two check slides to the lock bolt actuating mechanism (22) so that, when one of the two check slides is released, the lock bolt (17) can be moved to its unlocking position. A security slide (69, 70) is interposed between the pushbuttons and the tumbler members (33). The security slide is coupled to the lock bolt mechanism(17, 22) so that it is moved towards a position wherein it prevents the tumbler members (33) to be operated by the respective pushbuttons when the lock bolt mechanism is actuated to move the lock bolt (17) towards its unlocking position thereby preventing getting a tactile indication of which tumbler members (33) have to be depressed to unlock the lock.
Patent PT-2222291-E (PT)
Title: Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
Inventor: BELLINVIA SALVATORE
IPC: A61K31/196
Filed: 2008-12-23
Abstract: In one aspect, the present invention relates to amino-salicylic - aminophenylpropionic compounds for the use in the treatment of the inflammatory component of the celiac disease. These compounds act by blocking the cytokines released in the celiac disease and are specifically useful in the treatment of cases refractory to the diet, in dietary errors and in the reduction of the celiac disease remission time.
Patent PT-2213923-E (PT)
Title: Swivel joint
Inventor: LARSSON THOMAS
IPC: F16L19/02
Filed: 2009-01-30
Abstract: A swivel joint comprises a pipe part and a swivel nut (2). The pipe part has a first end (4a) and a second end (4b) and the swivel nut (2) has a first end (11 a) and a second end (11 b). The swivel nut (2) is positioned on the pipe part such that the first end (11 a) of the swivel nut (2) forms a swivel connection with the first end (4a) of the pipe part. The swivel nut (2) and the pipe part comprise shoulders (10, 17) against each other for preventing separation of the swivel nut (2) from the pipe part. The swivel nut (2) is made such that the swivel nut (2) and the pipe part are connected together by pushing the first end (11 a) of the swivel nut (2) towards the first end (4a) of the pipe part whereby the swivel nut (2) and the pipe part are connected by a snap joint.
Patent PT-2070948-E (PT)
Title: Humanized anti-cd4 antibody with immunosuppressive properties
Inventor: JONULEIT HELMUT
IPC: C12N15/13
Filed: 2004-03-19
Abstract: Provided is a humanized anti-CD4 antibody which is capable of activating CD4 +  CD25 +  regulatory T cells, wherein the humanized anti-CD4 antibody comprises a sequence comprising the complementarity-determining regions (CDRs) of the mouse monoclonal anti-CD4 antibody B-F5, optionally with variations in the sequence that do not substantially affect the antibody specificity and/or affinity thereof.
Patent PT-2394326-E (PT)
Title: Method for managing the heat in an electric battery
Inventor: GABEN FABIEN
IPC: B60L11/18
Filed: 2010-02-09
Abstract: Methods for managing the heat in an electric battery, including, when recharging said battery, preconditioning at an average temperature T0 and, when using said battery, determining the difference &Dgr;T1 between the temperatures of the hottest element and of the coolest element and as the absolute value &Dgr;T2 of the difference between the temperature T0 and the average temperature T of said battery. The method includes, when the difference &Dgr;T1 is lower than a first setpoint C1, deactivating the circulating device and as the heat-conditioning devices and, when the difference &Dgr;T1 is higher than a first setpoint C1 or when the difference &Dgr;T2 is higher than a second setpoint C2, activating the fluid-circulating device while keeping the heat-conditioning devices deactivated if the difference &Dgr;T2 is lower than the second setpoint C2, or while activating a heat-conditioning device if the difference &Dgr;T2 is higher than the second setpoint C2.
Patent PT-496327-E (PT)
Inventor: GUNZLER WOLFGANG A
IPC: C12R1/19
Filed: 1992-01-20
Abstract: Polypeptides of the general formula Ser-X1-X2-rscuPA<143-411> (1) in which X1 and X2 are defined amino acids or lower peptide bridges, X2 can also be a single bond, and rscuPA<143-411> is the unglycosylated sequence region of amino acids 143 (Glu) to 411 (LeuOH) from scu-PA 54 k, which can be used as plasminogen activators are described. To obtain these compounds, plasmids which are described in detail as such or in terms of their isolation were produced and expression thereof in suitable bacterial hosts provides, in each case in high yields, an expression product which does not act as plasminogen activator but whose protein-chemical conversion then leads to the single-chain compounds of the formula I which are valuable as plasminogen activators. <IMAGE>
Patent PT-573218-E (PT)
Inventor: YANAGISAWA HIROAKI
IPC: C07D405/14
Filed: 1993-05-27
Abstract: Compounds of formula (I): <CHEM> [in which: R<1> is hydrogen, alkyl, cycloalkyl or alkanoyl; R<2> is a single bond, alkylene or alkylidene; R<3> and R<4> are each hydrogen or alkyl; R<6> is carboxy or tetrazol-5-yl; and X is oxygen or sulphur]; and pharmaceutically acceptable salts and esters thereof are AII antagonists and can be used for the treatment and prophylaxis of hypertension and cardiovascular diseases.
Patent PT-612699-E (PT)
Inventor: KIRKMAN RICHARD THOMAS
IPC: C03B9/38
Filed: 1994-02-22
Abstract: A mold cooling apparatus comprising a pair of complementary mold arms (10), each arm supporting mold halves (13) such that when the arms are moved toward one another the molds halves form plural cavities (C). Each mold arm (10) supports a first air chamber (15) to which air under pressure is supplied and a second air chamber (16) communicating with the first chamber and having an opening (28) facing substantially the entire length of each mold half (13). A diffuser plate (18) closes each second chamber (16) and is positioned in close proximity with its respective mold half (13). The diffuser plate (18) has openings (19) for directing air from the second chamber (16) against the mold half (13). Each mold half has axial exhaust openings (20) extending from the space (24) between the mold half (13) and the exterior. The mold cooling apparatus can be applied to individual cavity as well as multi-cavity mold equipment. When a multi-cavity configuration is used, supplemental cooling is utilized through introduction of compressed air from a secondary source to axial and interconnected passages within the mold halves. <IMAGE>
Patent PT-624371-E (PT)
Inventor: SELLES JEAN-PHILIPPE
IPC: A61K31/60
Filed: 1994-04-19
Abstract: The invention relates to controlled-release microcapsules of acetylsalicyclic acid, which comprise acetylsalicyclic acid particles between 100 and 1000  mu m in size coated with a coating material consisting of mixture of a cellulosic film-forming polymer derivative, an anti-adhesive agent, a plasticizer, a lubricant and a vinylic film-forming polymer derivative. The invention also relates to a method of obtaining the abovementioned microcapsules.
Patent PT-700776-E (PT)
Inventor: BOE HANS PETER
IPC: C04B24/26
Filed: 1995-08-05
Abstract: A construction (1) made of concrete (2) with ≥ 1 pane of glass (4) at the front has the following features: (1.1) the glass has a coating (5) of composite mortar (I) on the inside; (1.2) the mortar (I) consists of finely divided neutral aggregate and cement mixed with an aq. dispersion of a polyacrylic acid deriv. (II) with a max. logarithmic decrement (DIN 53445) < 0 degrees C; (1.3) mortar (I) is hardened on the glass with a deficiency of hydration water; and (1.4) the coating (5) forms a solid bond with the concrete (2). The amt. of deriv. (II) and the thickness of the mortar are adjusted so that thermal expansion of the glass occurs without cracking. Also claimed is a process for the assembly of this construction.
Patent PT-687706-E (PT)
Inventor: LIBERT DANIEL
IPC: B65D41/00
Filed: 1995-06-06
Abstract: Polyolefin compsns. comprise 100 pts. wt. polyolefin, 0.1-5 pts. wt. lubricant and 0.05-2 pts. wt. zeolite. The zeolite is a crystalline aluminosilicate with a water adsorption capacity of 10 wt.% or less, measured at 25[deg]C and a water vapour partial pressure of 4.6 torr.
Patent PT-759942-E (PT)
Inventor: ANDERSON DIRK M
IPC: C07K14/715
Filed: 1995-05-04
Abstract: There are disclosed Interleukin-15 Receptor (IL-15R) proteins, DNAs and expression vectors encoding IL-15R, and processes for producing IL-15R as products of recombinant cell cultures. Also disclosed are monoclonal antibodies that bind Interleukin-15 receptors.
Patent PT-745584-E (PT)
Inventor: LESIEUR ISABELLE
IPC: C07D311/92
Filed: 1996-05-30
Abstract: Arylalkyl (thio)carboxamides of formula (I) A-B-C(=X)-NH-R1 their enantiomers and diastereoisomers and their salts, are new except for N-methyl-3-(4-methoxy-naphth-1-yl)propionamide or N-tert. butyl-3-carboxy-4-(naphth-1-yl)butyramide. In (I), A = a gp. of formula (i); Het Y gp. = (dihydro)naphthalene, tetrahydronaphthalene, (2,3-dihydro)benzofuran, (2,3-dihydro)benzothiophene, indole, indoline, 2H-indene or indane; Ra-Rc = H, halo, OH, Rd or ORd; Rd = alkyl (opt. substd by halo, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, opt. substd. aryl or opt. substd. aralkyl) or CRa+CRb = (dihydro)furan or (dihydro)pyran, opt. substd by OH, alkyl, alkoxy or oxo); B is a 2-6 membered alkylene chain opt. substd by alkyl, alkoxy, OH, carboxy, alkoxycarbonyl, carboxyalkyl, and alkoxycarbonylalkyl; X = O or S; and R1 = alkyl, halo-substd alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl; with provisos.
Patent PT-874847-E (PT)
Inventor: BISAGNI EMILE
IPC: C07D473/32
Filed: 1996-11-29
Abstract: Purine derivatives of formula (I) in optically-active or racemic forms and optionally as geometric isomers, having an IC50 ≤ 5 mu M for cdc2/cyclin B (cdc = catalytic subunit of a cyclin-dependent protein kinase (cdk); cyclin = the regulatory subunit) are new. In (I), R2, R6 and R9 = halo, RNH, RNH-NH, NH2-R'-NH- or RNH-R'-NH-; R = alkyl, aryl, cycloalkyl or heterocyclyl; R' = alkylene, arylene or cycloalkylene; both R and R' have 1-8 C and are optionally substituted by OH, halo, amino or alkyl; R2 may also be heterocyclyl, optionally substituted by R; R9 may also be alkyl, aryl or cycloalkyl; R2 and R9 can also be H but with provisos e.g.(a) R6, R9 = benzylamino and Me; and (b) R2, R6 = 2-hydroxyethylamino and benzylamino.
Patent PT-886667-E (PT)
Inventor: PRIOU CHRISTIAN
IPC: C08G59/68
Filed: 1997-03-11
Abstract: The present invention relates to initiators for the polymerization and/or crosslinking, cationically and under photochemical and/or thermal activation and/or activation by a beam of electrons, of monomers and/or polymers containing organofunctional groups. The said initiators are of the type comprising an onium salt of an element from groups 15 to 17 of the Periodic Table (Chem & Eng News, Vol 63, N5, 26, of 4 Feb. 1985) and they are characterized in that they contain at least one polymerization and/or crosslinking accelerator chosen from  alpha -hydroxylated carboxylic acid esters such as, for example, lactic acid esters. Another subject of the invention is compositions based on at least one cationically crosslinkable polyorganosiloxane and on at least one initiator.
Patent PT-873129-E (PT)
Inventor: GOTO TAKESHI
IPC: A61P3/06
Filed: 1997-10-15
Abstract: Disclosed are cholesterol-depressant, coated or non-coated tablets for oral administration, which comprise an anion exchange resin of formula (I):wherein X represents a physiologically-acceptable counter ion; and p represents an average degree of polymerization, and is larger than 10,000,silicon dioxide and crystalline cellulose, but not containing water. The non-coated tablets are preferably coated with cellulosic substances. The tablets are easy to take, as being not bitter. The dose of the tablets can be decreased, since the tablets can contain a large amount of the active ingredient. The mixture comprising the constituent components can be directly tabletted in the absence of water.
Patent PT-998352-E (PT)
Inventor: MOLES DONALD R
IPC: G01N37/00
Filed: 1998-07-20
Abstract: A microfluidic analyzer module is constructed of a plurality of channel forming laminate layers that are directly bonded together without adhesive or other possible contaminant source located proximate the flow channels. The channel forming laminate layers define a network of fluid flow channels. A valve containing layer is directly, adhesivelessly bonded over the channel containing layers. A flexible valve member integral with the valve layer opens and closes communication between feed and sensor channels of the channel network.
Patent PT-1000189-E (PT)
Inventor: GUILHEM MARC
IPC: D05B1/20
Filed: 1998-07-09
Abstract: A sewing method having a tension thread, guided and set in a passage of a stitch moved laterally relative to stitching devices between a normal position and a releasing position wherein the tension thread is laterally spaced out of the passage.
Patent PT-1024708-E (PT)
Inventor: VADEHRA DHARAM VIR
IPC: A23L27/10
Filed: 1998-10-07
Abstract: A process for the preparation of a substantially free flowing particulate flavor by mixing an oil soluble flavor with a melted edible fat having a melting point from about 30° C. (85° F.) to 93° C. (200° F.) to form a solution of the oil soluble flavor in the melted fat, cooling the solution of the oil soluble flavor in the melted fat, with the addition of a super-cooling agent with agitation during cooling, to produce solid particles having an average diameter of from about 0.1 to 10 cm, and then, if desired, grinding these particles with a super-cooling agent to produce the substantially free flowing particulate flavor whose particles have an average diameter of less than 1 mm.
Patent PT-1072604-E (PT)
Inventor: JOHANNES PLATZEK DR
IPC: A61K33/06
Filed: 1999-09-09
Abstract: Calcium complex of (4R)-4-(bis(carboxymethyl)amino)-6,9-bis(carboxymethyl)-1-(4,4-dipheny lcyclohexyloxy)-1-hydroxy-2-oxa-6,9-diaza-1-phospha-11-undecan oic acid (MS-325) and its salts are new. Calcium complex of ((4R)-4-(bis((carboxy-kappa-O)methyl) amino). kappa.N)-6,9-bis((carboxy-kappa.O)methyl)-1-((4,4-diphenylcyclohexyl)o xy)-1-hydroxy-2-oxa-6,9-diaza-1-phospha-11-undecanoic acid.kappa.N6,.kappa. N9,. kappa.011)1-oxidato (6-))-hexahydrogen (MS-325) and its salts are new. Independent claims are also included for the following: (1) a pharmaceutical composition comprising the calcium complex (Ca-MS-325) and optionally a gadolinium complex of MS-325 (Gd-MS-325); (2) production of a Gd-MS-325 formulation by reacting gadolinium oxide with MS-325 in the presence of a buffer, an (in)organic base and Ca-MS-325; (3) production of a Gd-MS-325 formulation by reacting gadolinium oxide with a MS-325 salt and adding Ca-MS-325.
Patent PT-1164911-E (PT)
Inventor: BERFIELD ROBERT C
IPC: F16K37/00
Filed: 1999-08-11
Abstract: A vacuum cleaner has an electric motor driving an air impeller for creating low pressure and a pump which draws liquid material through an inlet tube from the bottom of a tank and expels it from the tank. A priming apparatus is disposed between the air impeller and the interior of the pump to place the interior of the pump in air flow communication with a low pressure area generated by the air impeller. With the interior of the pump in air flow communication with the low pressure area generated by the air impeller, the pump is able to draw liquid material received by the tank up through the pump inlet to prime the pump.
Patent PT-1127013-E (PT)
Inventor: BOUGAMONT JEAN-LOUIS
IPC: B65D47/34
Filed: 1999-10-05
Abstract: The invention relates to a dispenser for dispensing viscous liquids, which dispenser is designed to be mounted on a container; said dispenser being characterized in that it comprises a bowl (1) whose bottom is provided with an inlet orifice (10) equipped with a valve (11), and whose top is closed off by a piston (2) that is urged back into its high position by a spring (3) and that co-operates with the inside wall of the bowl to define a metering chamber (12), the wall of said chamber including an annular zone, all or part of which is elastically deformable so as to act, under the effect of the pressure generated inside the chamber (12) to release a passageway (P) via which the liquid can be removed, which passageway opens out peripherally to the outside.
Patent IE-37561-L (IE)
Title: Production of deacetoxycephalosporin c
IPC: C12R1/00
Filed: 1973-04-25
Abstract: 1377339 Producing desacetoxycephalosporin C ELI LILLY & CO 17 April 1973 [26 April 1972 (4) 9 April 1973] 18387/73 Heading C2C Desacetoxycephalosporin C is produced by aerobically cultivating a desacetoxycephalosporin C- and penicillin N-CO-producing micro-organism of the genus Cephalosporium, Emeicellopsis, Scopulariopsis, Paecilomyces or Diheterospora in aqueous nutrient medium and then isolating desacetoxycephalosporin C from the resulting culture medium. The preferred organisms are Cephalosporium chrysogenum ATCC 14615, Cephalosporium sp. NRRL 5445, 5446, 5447, 5712, 5716, 5718, 5719, 5720, 5721, 5722, 5723, 5724 and 5725; Emericellopsis sp. NRRL 5446, 5447, 5713, 5714 and 5717; Scopulariopsis sp. NRRL 5715; Paecilomyces carneus NRRL 5711; and Diheterospora chlamydosporia NRRL 5728. The product is isolated by acidifying the whole culture broth to about pH 2, filtering off the mycelium and adsorbing the product on carbon followed by elution with aqueous acetone.
[GB1377339A]
Patent IE-34606-L (IE)
Title: Apparatus for cooling particles
IPC: C04B2/10
Filed: 1970-06-22
Abstract: 1,258,737. Cooling materials discharged from furnaces. L. H. NIEMS. 23 June, 1970 [23 June, 1969], No. 30491/70. Heading F4B. Granular material discharged from a rotary kiln 10, e.g. lime, cement clinker, dolomite or expanded shale, enters a shaft cooler 12 through a grating 14, said shaft cooler comprising a fan 31 with inlet duct 33 and outlet duct 32 with plenum chamber 30 supplying cooling air through gaps 38 in superposed hopper section 18 and 19 and via ducts 43 through tuyeres 39, some of the air being drawn downwardly into a hood 23 surrounding discharge shoots 20 by a duct 34 connecting said hood 23 to said inlet duct 33. There are four hoppers 18, 19 discharging through the shoots 20 and co-operating shoots 21 in said hood 23 on to vibratory feeders discharging on to a conveyer belt 25. The inlet duct 33 is closed by a plate 42 with a metering orifice 41 and valves 35 and 36 are provided in the ducts 34 and 32. Most of the air escaping upwardly in shaft 12 is used as combustion air, the remainder passing by exhaust duct 50 to a coal pulverizing mill and air recirculated through duct 34 carries dust away from the discharge shoots.
[GB1258737A]
Patent FI-810742-L (FI)
Inventor: YAMAMOTO OSUMU
IPC: C03C13/00
Filed: 1981-03-10
Abstract: The inorganic fiber of this invention comprising as major constituents -% by weight -SiO2 40-50  -CaO 0-10 -MgO 15-25  -Fe2O3 + FeO 0-10 -Al2O3 5-15 -MnO 2-15 -  (provided that the total amount of CaO, Fe2O3, FeO and MnO is about 20% by weight) is excellent in alkali- and heat-resistances and is useful as a replacement of asbestos in asbestos-cement boards. Titanium oxide (TiO2) is contained in natural rocks or slags to be used for the meltable material as an impurity in the amount of about 2% by weight.
Patent FI-820275-L (FI)
Inventor: BROWN JAMES PETER
IPC: C08L97/02
Filed: 1982-01-28
Abstract: An organic polyisocyanate composition contains from 99 to 60 parts by weight of a liquid organic polyisocyanate and from 1 to 40 parts of a 90:10 to 10:90 mixture of a wax and a liquid ester having a molecular weight of at least 250, for example an alkyl ester of an aliphatic carboxylic acid derived from an alkyl alcohol containing from 3 to 30 carbon atoms and a saturated or unsaturated fatty acid containing from 10 to 25 carbon atoms. The composition is useful for the manufacture of sheets or moulded bodies by the hot- pressing of a lignocellulosic material and promotes release of the material from the press. The composition is preferably applied in the form of an aqueous emulsion.
Patent FI-823119-L (FI)
Inventor: GANSLANDT EUGEN CONRAD EMANUEL
IPC: C08J11/04
Filed: 1982-09-09
Abstract: Rubber crumb is subjected to direct reclaiming by being mixed with a plasticizer and optionally also a peptizer and, under agitation and supply of a gas atmosphere with controlled oxygen content and at a temperature of 130 DEG -200 DEG  C., heated at substantially atmospheric pressure to cause the rubber particles to react with oxygen and absorb </=10, preferably 0.5-5 liters of O2/kg of rubber particles.
Patent IE-35636-L (IE)
Title: Benzopyrans
IPC: C07D405/04
Filed: 1971-09-10
Abstract: 1360009 Chromene derivatives BEECHAM GROUP Ltd 9 Sept 1971 [14 Sept 1970] 42066/71 Heading C2C The invention comprises compounds of formula wherein R 1 is a C 1 -C 6 aliphatic group, R 2 is a C 1 -C 20 aliphatic group, R 3 is an optionally substituted C 1 -C 20 hydrocarbon group and X is OH or an ester, ether or salt thereof; and N- oxides, acid addition and quaternary salts thereof. These compounds are prepared by reduction with a borohydride of the corresponding quaternary pyridinium salt, or, e.g. the compounds in which X is OH may be O- acylated. Intermediates also prepared are the analogous 4 - (4 - pyridyl) - chromenes and -coumarins; and 1 - (4 - R - 2,6 - dihydroxyphenyl) - 1 - (4- pyridyl) - 3 - methylbut - 1 - en - 3 - ols, where R is Bu or n-hexyl. Therapeutic compounds for oral, parenteral or rectal administration comprise compounds of the above formula, which have cardiovascular and C.N.S., e.g. antihypertensive, activity.
[GB1360009A]
Patent IE-791164-L (IE)
Title: L-cysteine derivatives.
IPC: A61K31/195
Filed: 1979-08-08
Abstract: L-cysteine derivatives of formula <IMAGE> in which R is a lower alkoxycarbonyl or carboxy group, and salts thereof. The compounds have been found to have a mucolytic activity and low toxicity. Processes for the preparation of the compounds and medicaments containing them are described and exemplified.
[US4248890A]